NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘New Enterprise Associates’

20 February 2015

Illinois Teachers backs RRJ, Carlyle Japan amid $900m of new commitments

chicago illinois_sq The $44.8bn Illinois Teachers Retirement System (TRS) has backed RRJ Capital’s latest Asia fund amid $900m of new commitments.

19 February 2015

Sequoia, Redpiont and Enterprise lead $34m round in Springpath

data-centre-416230-m A trio of venture capital investors have led a $34m round in Springpath, a provider of enterprise-grade storage and data management software.

28 January 2015

VC-backed Zosano Pharma launches IPO

Pharmedium drugs Venture capital-backed biopharmaceutical company Zosano Pharma has launched for an Intial public offering, pricing its 4.5 million shares at $11 per share.

22 January 2015

NEA leads $56m Series B round for online gift card company Raise

Raise gift card US venture capital major New Enterprise Associates has led a $56m Series B financing round for online gift card marketplace Raise.

14 January 2015

RA Capital, NEA back biopharma company Cortendo with private placement

biotech virus lab Healthcare focused RA Capital Management has joined New Enterprise Associates and Broadfin Capital in backing listed biopharmaceutical company Cortendo in a private placement deal.

14 January 2015

NEA launches 15th fund with $2.5bn and promotes three, including two to partner

money-437272-m New Enterprise Associates is looking to raise $2.5bn through its 15th vehicle and has bulked up its investment team with three promotions.

13 January 2015

MongoDB brings outside investment to $311m with latest round

data storage_lrg Data management business MongoDB has picked up $80m of new financing from investors including New Enterprise Associates, Goldman Sachs and Sequoia Capital.

12 January 2015

Bessemer leads $37m Series D in Welltok

health healthcare drugs pills medication medical Bessemer Venture Partners has led a $37m Series D financing round in US-based health optimisation firm Welltok.

9 January 2015

Rare disease drug developer Vtesse nets $25m NEA-led Series A

pharma pills drugs treatment New Enterprise Associates has led a $25m Series A financing round for rare disease drug developer Vtesse.

9 January 2015

NEA, Atlas among VC backers $35m Surface Oncology Series A

Opsona research lab Cancer immunotherapy business Surface Oncology has picked up $35m of Series A financing from a string of venture capital firms.

Page 1 of 1012345...10...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015